• KOR
  • ENG
GenN Core Center Phase 1 “Presenting the future of xeno-transplantation in Korea.”

GenNBio Inc. developed the masterplan for the ‘GenN Core Center,’ the first domestic one-stop platform for xeno-transplantation, with the purpose of contributing to the promotion of human welfare through the commercialization of heterogeneous organs. This encompasses initiatives ranging from the development of heterogeneous organs as well as the development of new drugs and technologies for transplantation to, ultimately, the establishment of a clinic that specializes in transplantation. The phase 1 plan calls for the construction of a primate experiment building, which will study heterogeneous organs and technologies for new drugs, as well as a GMP facility and research facilities, which will produce medical supplies made from heterogeneous organs.
  • main_01.png
  • main_02.png
  • main_03.png

Space Information

  • 21,060.56Square meters
    floor areas
  • +3 / -1Three stories and
    One basement levels
  • 2022Project
    Completion

The mission of GenNBio is to “promote human welfare through the clinical adaptation of heterogeneous organs.” In Korea, 5.2 individuals pass away per day while awaiting a transplant, and the organ’s supply-to-demand ratio is 11.8%. The alternative to this shortage of transplantable organs is the development of heterogeneous organs, and GenNBio is taking the lead in helping people awaiting transplants by producing heterogeneous organs and related new drugs, as well as establishing a clinic that specializes in transplantation.
Located in Pyeongtaek, the GenN Core Center was designed to feature not just offices and laboratories but also a facility for breeding gnotobiotic pigs, a testing building where primates are used to assess the long-term safety of the organs, and a GMP building for making medicines. Furthermore, because there are not many foreign cases of a DPF facility for gnotobiotic pigs, and because it requires GLP and GMP clearances, GenNBio collaborated with designers and a wide range of consultants to develop a detailed and integrated masterplan.
The design of the plan took into account the interior and exterior circulation paths of the negative or positive pressure clean zone, the size of the cage that complies with the AAALAC-designated breed space scale, and the development of the SOP for GLP/GMP clearances. The CI of GenNBio that ‘symbolizes a life in which two different entities, namely a gene of an animal organ and a gene of a human being, are combined’ served as a motive, thereby the plan was materialized into an intersecting mass. To emphasize the symbolism, color points were added to the elevation pattern.
Thus, given the lack of similar facilities, research into heterogeneous organ technology is a challenging field with much more work to be done. We hope that with broad social acceptance and support, xeno-transplantation technology may be developed and applied more swiftly, opening up greater opportunities for mankind.

Keywords
detail_02.png
detail_03.png

GenN Core Center Phase 1

  • Location Yulbuk-li, Cheongbuk-myeon, Pyeongtaek-si, Gyeonggi-do
  • Program Research & Science
  • Area 21,061m²
  • Floors P-building(2 Stories, 1 Basement Level) / G-building(PIT Level, 3 Stories)
  • Year 2022
detail_04.png

Related Contents

제보하기 (Report Misconduct)

임직원의 직무윤리와 관련된 부정, 비리를 제보하는 곳입니다.

제보내용은 비공개로 접수, 처리되며 제보자의 신분은 철저하게 보호됩니다.
제보내용이 사실에 근거하지 않거나 자료가 불확실한 경우 처리되지 않을수 있으니
정확한 사실확인을 위해 가능한 구체적으로 작성하여 주시길 바랍니다.

  • TEL02-2184-5050
  • FAX02-2184-5977
  • EMAILethics_samoo@samoo.com
  • 우편/방문서울특별시 강동구 천호대로 1077 이스트센트럴타워 05340, 삼우종합건축사사무소 감사팀

※ 임금 및 기성체불 등 협력업체 관련 민원은 02-2184-5114로 문의바랍니다.

*필수 입력 사항입니다.

개인정보 활용동의

(주)삼우종합건축사사무소는 ‘제보하기’의 의견 접수와 관련하여 필요한 최소한의 개인정보를 수집하고 있습니다.

  • 수집 항목 : 이름, 연락처, 이메일
  • 수집·이용목적 : 본 제보의 사실 관계 확인 및 처리 내용 안내
  • 보유·이용 기간 : 목적달성시까지

위 사항에 동의하십니까?
개인정보 활용 동의를 거부할 권리가 있으며, 동의를 거부할 경우 제보하기 이용이 제한됩니다.